In this free webinar, learn how to validate R for clinical use while maintaining appropriate controls. The featured speakers will discuss how R and SAS can be usedIn this free webinar, learn how to validate R for clinical use while maintaining appropriate controls. The featured speakers will discuss how R and SAS can be used

How to Safely Harness R and SAS for Cutting-Edge and Validated Clinical Analytics, Upcoming Webinar Hosted by Xtalks

2026/02/05 22:01
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

In this free webinar, learn how to validate R for clinical use while maintaining appropriate controls. The featured speakers will discuss how R and SAS can be used together without undermining auditability and traceability. Attendees will gain insight into practical governance steps to manage package updates, versioning and reproducibility. The speakers will also discuss how validation practices support compliant clinical analytics outputs.

TORONTO, Feb. 5, 2026 /PRNewswire/ — Life sciences companies face increasing pressure to expand clinical analytics beyond traditional SAS workflows to support more flexible analyses, richer visualizations and faster access to evolving statistical methods. Using open-source languages such as R alongside the commercial SAS language provides access to distinct capabilities and methodologies enabled by the rapid evolution of open-source technology. This webinar will explore how to adopt R alongside SAS while maintaining the validation controls required for compliant clinical use.

With frequent changes and the ability for anyone to contribute, open-source languages rapidly evolve. However, these also introduce significant challenges for validation, a critical component of any technology used for the development and analysis of clinical data.

In this webinar, the featured speakers will outline a practical approach to validating R as an open-source technology. With this approach, attendees will be able to balance rapid adoption of evolving open-source technologies with appropriate controls to ensure that analytic outputs are valid and compliant for clinical use.

Register for this webinar to learn how clinical analytics can be validated when R and SAS are used together for compliant clinical data analysis.

Join experts from d-wise, an Instem Company, Phil Loucks, Commercial Director; and Jonathon Hollahan, Deputy General Manager, for the live webinar on Thursday, February 26, 2026, at 2pm EST (11am PST).

For more information, or to register for this event, visit How to Safely Harness R and SAS for Cutting-Edge and Validated Clinical Analytics.

ABOUT XTALKS

Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what’s next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/how-to-safely-harness-r-and-sas-for-cutting-edge-and-validated-clinical-analytics-upcoming-webinar-hosted-by-xtalks-302679005.html

SOURCE Xtalks

Market Opportunity
Edge Logo
Edge Price(EDGE1)
$0.09634
$0.09634$0.09634
-1.02%
USD
Edge (EDGE1) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor’s Strategy Buys $2,010,000 Worth of Bitcoin in One of the Firm’s Largest Acquisitions Ever

Michael Saylor’s Strategy Buys $2,010,000 Worth of Bitcoin in One of the Firm’s Largest Acquisitions Ever

The post Michael Saylor’s Strategy Buys $2,010,000 Worth of Bitcoin in One of the Firm’s Largest Acquisitions Ever appeared on BitcoinEthereumNews.com. Michael
Share
BitcoinEthereumNews2026/05/19 15:17
One Of Frank Sinatra’s Most Famous Albums Is Back In The Spotlight

One Of Frank Sinatra’s Most Famous Albums Is Back In The Spotlight

The post One Of Frank Sinatra’s Most Famous Albums Is Back In The Spotlight appeared on BitcoinEthereumNews.com. Frank Sinatra’s The World We Knew returns to the Jazz Albums and Traditional Jazz Albums charts, showing continued demand for his timeless music. Frank Sinatra performs on his TV special Frank Sinatra: A Man and his Music Bettmann Archive These days on the Billboard charts, Frank Sinatra’s music can always be found on the jazz-specific rankings. While the art he created when he was still working was pop at the time, and later classified as traditional pop, there is no such list for the latter format in America, and so his throwback projects and cuts appear on jazz lists instead. It’s on those charts where Sinatra rebounds this week, and one of his popular projects returns not to one, but two tallies at the same time, helping him increase the total amount of real estate he owns at the moment. Frank Sinatra’s The World We Knew Returns Sinatra’s The World We Knew is a top performer again, if only on the jazz lists. That set rebounds to No. 15 on the Traditional Jazz Albums chart and comes in at No. 20 on the all-encompassing Jazz Albums ranking after not appearing on either roster just last frame. The World We Knew’s All-Time Highs The World We Knew returns close to its all-time peak on both of those rosters. Sinatra’s classic has peaked at No. 11 on the Traditional Jazz Albums chart, just missing out on becoming another top 10 for the crooner. The set climbed all the way to No. 15 on the Jazz Albums tally and has now spent just under two months on the rosters. Frank Sinatra’s Album With Classic Hits Sinatra released The World We Knew in the summer of 1967. The title track, which on the album is actually known as “The World We Knew (Over and…
Share
BitcoinEthereumNews2025/09/18 00:02
Moody’s Assigns First-Ever Rating to Bitcoin-Backed Municipal Bond in Historic Crypto Finance Move

Moody’s Assigns First-Ever Rating to Bitcoin-Backed Municipal Bond in Historic Crypto Finance Move

TLDR: Moody’s assigned a provisional Ba2 rating to a $100M Bitcoin-backed New Hampshire municipal bond, a market first. The bond requires 160% Bitcoin overcollateralization
Share
Blockonomi2026/04/02 18:15

No Chart Skills? Still Profit

No Chart Skills? Still ProfitNo Chart Skills? Still Profit

Copy top traders in 3s with auto trading!